FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ...

Ferrosa Therapeutics AG ("FERROSA"), a Swiss biotechnology company developing a first-in-class bispecific antibody to treat ...